Bisphenol A: An endocrine and metabolic disruptor

Annales d'Endocrinologie

Volumn 74, Issue 3, 2013, Pages 211-220

  Fenichel, Patrick ^a   Chevalier, Nicolas ^a   Brucker Davis, Françoise ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN; AROMATASE; ATRAZINE; CHLORDECONE; DNA METHYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; GLUCOSE TRANSPORTER 4; INTERLEUKIN 6; TESTOSTERONE; THYROXINE; TRANSCRIPTION FACTOR HOXA10; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BLOOD LEVEL; BREAST CANCER; CRYPTORCHISM; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GERM CELL TUMOR; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; LONG TERM EXPOSURE; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PRENATAL EXPOSURE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SUBFERTILITY; TESTIS CANCER; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

EID: 84880331278     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2013.04.002     Document Type: Article

References (109)

1. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993, 101:378-384.
2. Colborn T., Clement C. Chemically induced alterations in sexual and functional development: the human/wildlife connection. Wingspread consensus statement. 1992, 1-8. Princeton Sicentifique Publishing, Princeton, New Jersey. N.J. Princeton (Ed.).
3. Toppari J., Larsen J.C., Christiansen P., et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996, 104(Suppl.4):741-803.
4. Herbst A.L. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 1997, 48:484-488.
5. Palmer J.R., Wise L.A., Hatch E.E., et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:1509-1514.
6. Barker D.J.P. The developmental origins of adult disease. Eur J Endocrinol 2003, 18:733-736.
7. ANSES. Rapport d'expertise collective. Effets sanitaires du bisphénol A. 2011.
8. Dodds E.C., Lawson W. Synthetic estrogenic agents without the phenanthrene nucleus. Nature 1936, 137:996.
9. Krishnan A.V., Stathis P., Permuth S.F., et al. Bisphenol A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
10. Calafat A.M., Kuklenyik Z., Reidy J.A., et al. Urinary concentrations of bisphenol A and 4-nonylphenol in ahuman reference population. Environ Health Perspect 2005, 113:391-395.
11. Vandenberg L.N., Hauser R., Marcus M., et al. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
12. Vom Saal F.S., Hughes C. An extensive new literature concerning low dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 2005, 113:926-933.
13. Lang I.A., Galloway T.S., Scarlett A., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
14. Vandenberg L.N., Maffini M.V., Sonnenschein C., et al. Bisphenol A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30:75-95.
15. Rubin B.S., Murray M.K., Damassa D.A., et al. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001, 109:675-680.
16. Somm E., Schwitzgebel V.M., Toulotte A., et al. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ Health Perspect 2009, 117:1549-1555.
17. Ryan K.K., Haller A.M., Sorrell J.E., et al. Perinatal exposure to bisphenol A and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010, 151:2603-2612.
18. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., et al. Exposure to bisphenol A advances puberty. Nature 1999, 401:763-764.
19. Newbold R.R., Padilla-Banks E., Snyder R.J., et al. Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 2007, 51:912-917.
20. Alonso-Magdalena P., Morimoto S., Ripoll C., et al. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006, 114:106-112.
21. Newbold R.R., Padilla-Banks E., Snyder R.J., et al. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 2007, 23:290-296.
22. Masuno H., Kidani T., Sekiya K., et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 2002, 43:676-684.
23. Wada K., Sakamoto H., Nishikawa K., et al. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 2007, 105:133-137.
24. Sargis R.M., Johnson D.N., Choudhury R.A., et al. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010, 18:1283-1288.
25. Hugo E.R., Brandebourg T.D., Woo J.G., et al. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008, 116:1642-1647.
26. Ben-Jonathan N., Hugo E.R., Brandebourg T.D. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 2009, 304:49-54.
27. Alonso-Magdalena P., Quesada I., Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 2011, 7:346-353.
28. Fernandez M.F., Arrebola J.P., Taoufiki J., et al. Bisphenol A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 2007, 24:259-264.
29. Philippat C., Mortamais M., Chevrier C., et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect 2012, 120:464-470.
30. Carwile J.L., Michels K.B. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011, 111:825-830.
31. Wang T., Li M., Chen B., et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012, 97:E223-E227.
32. Takeuchi T., Tsutsumi O., Ikezuki Y., et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004, 51:165-169.
33. Kandaraki E., Chatzigeorgiou A., Livadas S., et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 2011, 96:E480-E484.
34. Bindhumol V., Chitra K.C., Mathur P.P. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 2003, 188:117-124.
35. Sakurai K., Kawazuma M., Adachi T., et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004, 141:209-214.
36. Alonso-Magdalena P., Laribi O., Ropero A.B., et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a non-classical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 2005, 113:969-977.
37. Nadal A., Ropero A.B., Laribi O., et al. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor-alpha and estrogen receptor beta. Proc Natl Acad Sci U S A 2000, 97:11603-11608.
38. Quesada I., Fuentes E., Viso-León M.C., et al. Low doses of the endocrine disruptor bisphenol A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J 2002, 16:1671-1673.
39. Soriano S., Alonso-Magdalena P., García-Arévalo M., et al. Rapid insulinotropic action of low doses of bisphenol A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One 2012, 7:e31109.
40. Melzer D., Rice N.E., Lewis C., et al. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010, 5:e8673.
41. Silver M.K., O'Neill M.S., Sowers M.R., et al. Urinary bisphenol A and type-2 diabetes in US adults: data from NHANES 2003-2008. PLoS One 2011, 6:e26868.
42. Shankar A., Teppala S. Relationship between body mass index and high cystatin levels among US adults. J Clin Hypertens (Greenwich) 2011, 13:925-930.
43. Fernández M., Bourguignon N., Lux-Lantos V., et al. Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect 2010, 118:1217-1222.
44. Zhou W., Liu J., Liao L., et al. Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol 2008, 283:12-18.
45. Skakkebaeck N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001, 16:972-978.
46. Main K.M., Skakkebaek N.E., Toppari J. Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection. Endocr Dev 2009, 14:167-173.
47. Brucker-Davis F., Wagner-Mahler K., Delattre I., et al. Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations. Hum Reprod 2008, 23:1708-1718.
48. Fénichel P., Déchaux H., Harthe C., et al. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum Reprod 2012, 27:983-990.
49. Fénichel P, Lahlou N, Coquillard P, Pugeat M, Pacini P, Panaïa-Ferrari P, et al. Cord blood Insulin-like peptide 3 (INSL3) is reduced in idiopathic cryptorchidism: the missing link between fetal exposure to endocrine disruptors like bisphenol A and undescended testis? Oral communication presented at The Endocrine Society's Annual Meeting San Francisco June 15-18 2013.
50. Richter C.A., Birnbaum L.S., Farabollini F., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007, 24:199-224.
51. Nakamura D., Yanagiba Y., Duan Z., et al. Bisphenol A may cause testosterone reduction by adversely affecting both testis and pituitary systems similar to estradiol. Toxicol Lett 2010, 194:16-25.
52. Salian S., Doshi T., Vanage G. Neonatal exposure of male rats to bisphenol A impairs fertility and expression of sertoli cell junctional proteins in the testis. Toxicology 2009, 265:56-67.
53. Bouskine A., Nebout M., Brücker-Davis F., et al. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G protein coupled estrogen receptor. Environ Health Perspect 2009, 117:1053-1058.
54. Chevalier N., Bouskine A., Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int J Cancer 2012, 130:241-242.
55. Salian S., Doshi T., Vanage G. Perinatal exposure of rats to bisphenol A affects the fertility of male offspring. Life Sci 2009, 85:742-752.
56. Li D.K., Zhou Z., Miao M., et al. Urine bisphenol A (BPA) level in relation to semen quality. Fertil Steril 2011, 95:625-630.
57. Institut national de veille sanitaire: projections de l'incidence et de la mortalité par cancer en France en 2010: sein. http://www.invs.sante.fr/.
58. Sasco A.J. Epidemiology of breast cancer: an environmental disease?. Apmis 2001, 109:321-332.
59. Fénichel P., Brucker-Davis F. Environmental endocrine disruptors and breast cancer: new risk factors?. Gynecol Obstet Fertil 2008, 36:969-977.
60. Markey C.M., Luque E.H., Munoz De Toro M., et al. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001, 65:1215-1223.
61. Markey C.M., Wadi P.R., Rubin B.S., et al. Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol A in the female mouse genital tract. Biol Reprod 2005, 72:1344-1351.
62. Vandenberg L.N., Maffini M.V., Wadia P.R., et al. Exposure to environmentally relevant doses of the xenoestrogen bisphenol A alters development of the fetal mouse mammary gland. Endocrinology 2007, 148:116-127.
63. Durando M., Kass L., Piva J., et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 2007, 115:80-86.
64. van Meeuwen J.A., Ter Burg W., Piersma A.H., et al. Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells. Food Chem Toxicol 2007, 45:2319-2330.
65. Lapensee E.W., Tuttle T.R., Fox S.R., et al. Bisphenol A at low nanomolar doses confers chemo-resistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environ Health Perspect 2009, 117:175-180.
66. Brody J.G., Moysich K.B., Humblet O., et al. Environmental pollutants and breast cancer: epidemiologic studies. Cancer 2007, 109:2667-2711.
67. Rébillard X., Tretare B., Villers A. The epidemiology of prostate cancer. Rev Prat 2003, 53:2224-2228.
68. Prins G.S., Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008, 73:233-244.
69. Yomenura C.Y., Cunha G.R., Sugimura Y., et al. Temporal and spatial factors in diethylstilbestrol-induced sqamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol. Acta Anat 1995, 153:1-11.
70. Multigner L., Ndong J.R., Giusti A., et al. Chlordecone exposure and risk of prostate cancer. J Clin Oncol 2010, 28:3457-3462.
71. Prins G.S., Tang W.Y., Belmonte J., et al. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin Pharmacol Toxicol 2008, 102:134-138.
72. Esteller M. Aberrant DNA methylation as a cancer inducing mechanism. Ann Rev Pharmacol Toxicol 2005, 45:629-656.
73. Hess-Wilson J.K. Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer. Cancer Causes Control 2009, 20:1029-1037.
74. Bray F., Richiardi L., Ekbom A., et al. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006, 118:3099-3111.
75. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006, 12:303-323.
76. Mills P.K., Newell G.R., Johnson D.E. Testicular cancer-associated with employment in agriculture and oil and natural gas extraction. Lancet 1984, 1:207-210.
77. Mills P.K. Correlation analysis of pesticide use data and cancer incidence rates in California counties. Arch Environ Health 1998, 53:410-413.
78. Hardell L., van Bavel B., Lindström G., et al. Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 2003, 111:930-934.
79. Roger C., Lombard S., Mograbi B., et al. Human testicular seminoma cells express functional aromatase, estrogen receptor and can be regulated in vitro by estradiol. J Mol Endocrinol 2005, 35:191-199.
80. Bouskine A., Nebout M., Mograbi B., et al. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. Endocrinology 2008, 149:565-573.
81. Chevalier N., Vega A., Bouskine A., et al. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 2012, 7:e34672.
82. Vandenberg L.N., Chahoud I., Heindel J.J., et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010, 118:1055-1070.
83. Ho S.M., Tang W.Y., Belmonte de Frausto J., et al. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006, 66:5624-5632.
84. Moriyama K., Tagami T., Akamizu T., et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab. 2002, 87:5185-5190.
85. Chevrier J., Gunier R.B., Bradman A., et al. Maternal urinary bisphenol A during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ Health Perspect 2013, 121:138-144.
86. Shibata N., Matsumoto J., Nakada K., et al. Male-specific suppression of hepatic microsomal UDP-glucuronosyl transferase activities toward sex hormones in the adult male rat administered bisphenol A. Biochem J 2002, 368:783-788.
87. Brucker-Davis F., Ferrari P., Boda-Buccino M., Wagner-Mahler K., Pacini P., Gal J., et al. Cord blood thyroid tests in boys born with and without cryptorchidism: correlations with birth parameters and in utero xenobiotics exposure. Thyroid 2011, 10:1133-1141.
88. Völkel W., Colnot T., Csanády G.A., et al. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 2002, 15:1281-1287.
89. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008, 228:114-134.
90. Ginsberg G., Rice D.C. Does rapid metabolism ensure negligible risk from bisphenol A?. Environ Health Perspect 2009, 117:1639-1643.
91. Matsumoto J., Yokota H., Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyl transferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect 2002, 110:193-196.
92. Coughtrie M.W., Burchell B., Leakey J.E., et al. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyl transferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 1988, 34:729-735.
93. Kaddar N., Bendridi N., Harthé C., et al. Development of a radioimmunoassay for the measurement of bisphenol A in biological samples. Anal Chim Acta 2009, 645:1-4.
94. Olsen C.M., Meussen-Elholm E.T., Samuelsen M., et al. Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4'-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. Pharmacol Toxicol 2003, 92:180-188.
95. Sharpe R.M. Is it time to end concerns over the estrogenic effects of bisphenol A?. Toxicol Sci 2010, 114:1-4.
96. Okada H., Tokunaga T., Liu X., et al. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect 2008, 116:32-38.
97. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008, 29:677-696.
98. Pupo M., Pisano A., Lappano R., et al. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect 2012, 120:1177-1182. [Epub ahead of print].
99. Sun H., Xu L.C., Chen J.F., et al. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene. Food Chem Toxicol 2006, 44:1916-1921.
100. Wright H.M., Clish C.B., Mikami T., et al. A synthetic antagonist for the peroxisome proliferator-activated receptor-gamma inhibits adipocyte differentiation. J Biol Chem 2000, 275:1873-1877.
101. Zoeller R.T., Bansal R., Parris C., Bisphenol A. an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005, 146:607-612.
102. Bromer J.G., Wu J., Zhou Y., et al. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 2009, 150:3376-3382.
103. Li S., Hansman R., Newbold R., et al. Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 2003, 38:78-84.
104. Bromer J.G., Zhou Y., Taylor M.B., et al. Bisphenol A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 2010, 24:2273-2280.
105. Fei X., Chung H., Taylor H.S. Methoxychlor disrupts uterine HOXA10 gene expression. Endocrinology 2005, 146:3445-3451.
106. Esteller M., Aberrant K. DNA methylation as a cancer inducing mechanism. Ann Rev Pharmacol Toxicol 2005, 45:629-656.
107. Tang W.Y., Newbold R., Mardilovitch M., et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 2008, 149:5922-5939.
108. Volle D.H., Decourteix M., Garo E., et al. The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice. J Clin Invest 2009, 119:3752-3764.
109. Chiam K., Tilley W.D., Butler L.M., et al. The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers. Biochim Biophys Acta 2009, 1795:104-109.